# Trifluridine/Tipiracil Plus Fruquintinib vs. Trifluridine/Tipiracil Plus Bevacizumab in Refractory Metastatic Colorectal Cancer: A Randomized, Controlled, Open-

Source: https://onco.cc/trials/nct07261709/  
OnCo record `nct07261709` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in colorectal cancer, run by Sun Yat-sen University, not yet recruiting.

## Summary

Trifluridine/Tipiracil Plus Fruquintinib vs. Trifluridine/Tipiracil Plus Bevacizumab in Refractory Metastatic Colorectal Cancer: A Randomized, Controlled, Open-Label, Non-Inferiority Trial is a phase 2, randomised interventional study registered as NCT07261709 by Sun Yat-sen University, with a registry enrolment figure of 236 participants, started 2025-12-01 and due to reach its primary completion in 2027-10-30. Interventions recorded: Trifluridine/tipiracil plus fruquintinib; trifluridine/tipiracil plus bevacizumab. Conditions listed: Refractory Metastatic Colorectal Cancer. Primary outcome: PFS. Colorectal eligibility wording from the registry: "Histologically confirmed unresectable colorectal cancer". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT07261709
- Phase: 2
- Setting: Trifluridine/Tipiracil Plus Fruquintinib vs. Trifluridine/Tipiracil Plus Bevacizumab in Refractory Metastatic Colorectal Cancer: A Randomized, Controlled, Open-Label, Non-Inferiority Trial
- Sponsor: Sun Yat-sen University
- Enrolled: 236

## Sources

- ClinicalTrials.gov NCT07261709: https://clinicaltrials.gov/study/NCT07261709

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07261709.json